Status: current, Defined. Date: 31-Oct 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4624971000168118 | Erlotinib (Cipla) (erlotinib 25 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4624981000168115 | Erlotinib (Cipla) 25 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Erlotinib (Cipla) 25 mg tablet | Is a | Erlotinib (Cipla) | true | Inferred relationship | Some | ||
| Erlotinib (Cipla) 25 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Erlotinib (Cipla) 25 mg tablet | Is a | erlotinib 25 mg tablet | true | Inferred relationship | Some | ||
| Erlotinib (Cipla) 25 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Erlotinib (Cipla) 25 mg tablet | has Australian BoSS | erlotinib | true | Inferred relationship | Some | 2086603947 | |
| Erlotinib (Cipla) 25 mg tablet | has intended active ingredient | erlotinib | true | Inferred relationship | Some | 2086603947 | |
| Erlotinib (Cipla) 25 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 604614071 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Erlotinib (Cipla) 25 mg tablet, 30, blister pack | has TPUU | True | Erlotinib (Cipla) 25 mg tablet | Inferred relationship | Some | 1198249805 |
| Erlotinib (Cipla) 25 mg tablet, 30 | has TPUU | True | Erlotinib (Cipla) 25 mg tablet | Inferred relationship | Some | 323171063 |
Reference Sets
Trade product unit of use reference set
FHIR